Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000302 · ClinicalTrials.gov registry record · Phase 3

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

A Phase 3 study of Heroin Dependence, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
Phase 3
Development phase
1
Study location

NCT00000302: Completed Phase 3 study of Heroin Dependence, sponsored by National Institute on Drug Abuse (NIDA).

NCT00000302 is a Phase 3 study of Heroin Dependence that has completed, run by National Institute on Drug Abuse (NIDA). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000302, a Phase 3 study of Heroin Dependence, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
Phase 3
Development phase
1
Study location

Study Summary

The purpose of this study is to compare liquid and tablet buprenorphine formulations.

Conditions Studied

Heroin Dependence

Interventions

  • DRUG Buprenorphine

Study Locations (1)

California

  • Friends Research Institute - Los Angeles

Trial Details

FieldValue
Phase Phase 3
National Institute on Drug Abuse (NIDA)

335 total trials

What the finished NCT00000302 record still lists

NCT00000302 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Heroin Dependence appearing as the primary indexed condition, and to 1 intervention - of which Buprenorphine is the first listed.

NCT00000302 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00000302 about?

NCT00000302 is a clinical study titled "Study Comparing Liquid and Tablet Buprenorphine Formulations - 5". The purpose of this study is to compare liquid and tablet buprenorphine formulations.

What is the current status of trial NCT00000302?

This trial is currently completed. It is a Phase 3 study.

What conditions does trial NCT00000302 study?

This clinical trial studies the following conditions: Heroin Dependence.

What interventions are being tested in trial NCT00000302?

The interventions under investigation include: Buprenorphine (DRUG).

Who is sponsoring clinical trial NCT00000302?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000302 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heroin Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00000302, the US trial registry maintained by the National Library of Medicine. NCT00000302 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.